Skip to main content
Top
Published in: Current Gastroenterology Reports 8/2017

01-08-2017 | Inflammatory Bowel Disease (S Hanauer, Section Editor)

Quality Improvement Initiatives in Inflammatory Bowel Disease

Authors: Sameer K. Berry, Corey A. Siegel, Gil Y. Melmed

Published in: Current Gastroenterology Reports | Issue 8/2017

Login to get access

Abstract

Purpose of Review

This article serves as an overview of several quality improvement initiatives in inflammatory bowel disease (IBD).

Recent Findings

IBD is associated with significant variation in care, suggesting poor quality of care. There have been several efforts to improve the quality of care for patients with IBD. Quality improvement (QI) initiatives in IBD are intended to be patient-centric, improve outcomes for individuals and populations, and reduce costs—all consistent with “the triple aim” put forth by the Institute for Healthcare Improvement (IHI).

Summary

Current QI initiatives include the development of quality measure sets to standardize processes and outcomes, learning health systems to foster collaborative improvement, and patient-centered medical homes specific to patients with IBD in shared risk models of care. Some of these programs have demonstrated early success in improving patient outcomes, reducing costs, improving patient satisfaction, and facilitating patient engagement. However, further studies are needed to evaluate and compare the effects of these programs over time on clinical outcomes in order to demonstrate long-term value and sustainability.
Literature
2.
go back to reference Altschuler A, Collins B, Lewis JD, Velayos F, Allison JE, Hutfless S, et al. Gastroenterologists’ attitudes and self-reported practices regarding inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:992–9.CrossRefPubMed Altschuler A, Collins B, Lewis JD, Velayos F, Allison JE, Hutfless S, et al. Gastroenterologists’ attitudes and self-reported practices regarding inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:992–9.CrossRefPubMed
3.
go back to reference • Weaver KN, Kappelman MD, Sandler RS. Variation in care of inflammatory bowel diseases patients in Crohnʼs and Colitis Foundation of America Partners. Inflamm Bowel Dis. 2016;22(11):2672–7. This article provides recent and objective data about the variation in IBD care by GI physicians. It also explains how variation in care is an indication of low quality care CrossRefPubMed • Weaver KN, Kappelman MD, Sandler RS. Variation in care of inflammatory bowel diseases patients in Crohnʼs and Colitis Foundation of America Partners. Inflamm Bowel Dis. 2016;22(11):2672–7. This article provides recent and objective data about the variation in IBD care by GI physicians. It also explains how variation in care is an indication of low quality care CrossRefPubMed
4.
go back to reference Spiegel BMR, Ho W, Esrailian E, Targan S, Higgins PDR, Siegel CA, et al. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists. Clin Gastroenterol Hepatol. 2009;7:168–74.CrossRefPubMed Spiegel BMR, Ho W, Esrailian E, Targan S, Higgins PDR, Siegel CA, et al. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists. Clin Gastroenterol Hepatol. 2009;7:168–74.CrossRefPubMed
5.
go back to reference Kappelman MD, Bousvaros A, Hyams J, Markowitz J, Pfefferkorn M, Kugathasan S, et al. Intercenter variation in initial management of children with Crohn’s disease. Inflamm Bowel Dis. 2007;13:890–5.CrossRefPubMed Kappelman MD, Bousvaros A, Hyams J, Markowitz J, Pfefferkorn M, Kugathasan S, et al. Intercenter variation in initial management of children with Crohn’s disease. Inflamm Bowel Dis. 2007;13:890–5.CrossRefPubMed
6.
go back to reference Crandall WV, Margolis PA, Kappelman MD, King EC, Pratt JM, Boyle BM, et al. Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease. Pediatrics. 2012;129:e1030–41.CrossRefPubMedPubMedCentral Crandall WV, Margolis PA, Kappelman MD, King EC, Pratt JM, Boyle BM, et al. Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease. Pediatrics. 2012;129:e1030–41.CrossRefPubMedPubMedCentral
10.
go back to reference • Melmed GY, Siegel CA, Spiegel BM, Allen JI, Cima R, Colombel JF, et al. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 2013;19(3):662–8. This article goes into detail as to how the process and outcome measures were created which is important because it may lay the groundwork for further QI intiatives and future process/outcome measure sets CrossRefPubMed • Melmed GY, Siegel CA, Spiegel BM, Allen JI, Cima R, Colombel JF, et al. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 2013;19(3):662–8. This article goes into detail as to how the process and outcome measures were created which is important because it may lay the groundwork for further QI intiatives and future process/outcome measure sets CrossRefPubMed
16.
go back to reference Crandall W, Kappelman MD, Colletti RB, Leibowitz I, Grunow JE, Ali S, et al. ImproveCareNow: the development of a pediatric inflammatory bowel disease improvement network. Inflamm Bowel Dis. 2011;17:450–7.CrossRefPubMed Crandall W, Kappelman MD, Colletti RB, Leibowitz I, Grunow JE, Ali S, et al. ImproveCareNow: the development of a pediatric inflammatory bowel disease improvement network. Inflamm Bowel Dis. 2011;17:450–7.CrossRefPubMed
19.
go back to reference • Regueiro MD, McAnallen SE, Greer JB, Perkins SE, Ramalingam S, Szigethy E. The inflammatory bowel disease specialty medical home: a new model of patient-centered care. Inflamm Bowel Dis. 2016;22:1971–80. This article describes the concept of a subspecialty medical home for patients with inflammatory bowel disease, including comprehensive, multidisciplinary care and a novel shared savings program CrossRefPubMed • Regueiro MD, McAnallen SE, Greer JB, Perkins SE, Ramalingam S, Szigethy E. The inflammatory bowel disease specialty medical home: a new model of patient-centered care. Inflamm Bowel Dis. 2016;22:1971–80. This article describes the concept of a subspecialty medical home for patients with inflammatory bowel disease, including comprehensive, multidisciplinary care and a novel shared savings program CrossRefPubMed
21.
go back to reference Kosinski L, et al. Project Sonar: reduction in cost of care in an attributed cohort of patients with Crohn’s disease. Gastroenterology. 2016;150:s173.CrossRef Kosinski L, et al. Project Sonar: reduction in cost of care in an attributed cohort of patients with Crohn’s disease. Gastroenterology. 2016;150:s173.CrossRef
22.
go back to reference Kosinski, Lawrence R. MD. Project Sonar: a solution for change. EndoEconomics. 2015;5–7. Kosinski, Lawrence R. MD. Project Sonar: a solution for change. EndoEconomics. 2015;5–7.
Metadata
Title
Quality Improvement Initiatives in Inflammatory Bowel Disease
Authors
Sameer K. Berry
Corey A. Siegel
Gil Y. Melmed
Publication date
01-08-2017
Publisher
Springer US
Published in
Current Gastroenterology Reports / Issue 8/2017
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-017-0581-x

Other articles of this Issue 8/2017

Current Gastroenterology Reports 8/2017 Go to the issue

Stomach and Duodenum (J Pisegna and J Benhammou, Section Editors)

Changing Trends in Stomach Cancer Throughout the World

Esophagus (J Clarke and N Ahuja, Section Editors)

Hiatus Hernia as a Cause of Dysphagia

Stomach and Duodenum (J Pisegna and J Benhammou, Section Editors)

The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors

Pediatric Gastroenterology (S Orenstein, Section Editor)

Clostridium Difficile, Colitis, and Colonoscopy: Pediatric Perspective

Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract (S Rao, Section Editor)

Chicago Classification of Esophageal Motility Disorders: Lessons Learned

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.